A case study of lung cancer patients in term of various risk factors in context of Bangladesh

A case study of lung cancer patients in term of various risk factors in context of Bangladesh

This thesis is submitted in partial fulfilment of the requirements for the degree of Bachelor of Science in Microbiology, 2018.

Бібліографічні деталі
Автор:	Shabnam, Musharrat
Інші автори:	Islam, Mohammad Rafiqul
Формат:	Дисертація
Мова:	English
Опубліковано:	BRAC University 2018
Предмети:	Lung cancer Chronic obstructive pulmonary disease Ahsania Mission Cancer Hospital Lungs - Cancer HEALTH & FITNESS - Diseases - Cancer MEDICAL - Oncology.
Онлайн доступ:	http://hdl.handle.net/10361/10726

Схожі ресурси

Molecules associated with the development of lung cancer
за авторством: Rahman, Adree, та інші
Опубліковано: (2023)

A cross-sectional study on risk factors, symptoms, treatment and management strategies of lung cancer in a tertiary care cancer hospital of Bangladesh
за авторством: Pial, Sazia Afrin
Опубліковано: (2018)

Protein biomarkers for Lung Cancer: a bioinformatic approach
за авторством: Jeba, Joynob
Опубліковано: (2017)

A review on targeted therapies for lung cancer
за авторством: Ashraf, Anushey
Опубліковано: (2023)

An overview of the clinical management and challenges of treatments for the patients diagnosed with COVID-19 and lung carcinoma
за авторством: Bristy, Israt Zerin
Опубліковано: (2021)

Potential of liposomes for the treatment of lung cancer- a review
за авторством: Mim, Shanzida
Опубліковано: (2023)

A review on recent advances in drugs for lung cancer treatment
за авторством: Noor, Fouzia
Опубліковано: (2024)

Impact of treatment size and therapy type in phase II clinical trials of non-small cell lung cancer
за авторством: Rahman, Tasnim
Опубліковано: (2024)

Recent developments in the Adeno-Associated Viral Gene Therapy for Non-Small Cell Lung Cancer during the past 20 years
за авторством: Razna, Amrin Islam
Опубліковано: (2019)

Targeted treatment in patients with non-small cell lung cancer: Use of Bevacizumab and its Biosimilars
за авторством: Tania, Umme
Опубліковано: (2023)

Efficacy analysis and prediction in phase II clinical trials of non-small cell Lung Cancer
за авторством: Hoque, Ismoth Ara
Опубліковано: (2024)

Effect of performance status on efficacy endpoints in phase II trials of non-small cell lung cancer
за авторством: Paul, Pulock
Опубліковано: (2024)

Bioinformatics analyses of key regulators of NF-κB pathway in relation with small cell lung carcinoma
за авторством: Zangmo, Thinley
Опубліковано: (2024)

Immunotherapy in the Management of Lung Cancer
за авторством: Tasnim, Humayra
Опубліковано: (2022)

Efficacy analysis of tyrosine kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Flora, Sanzida Alam
Опубліковано: (2024)

Lung cancer detection and classification using machine learning
за авторством: Arefin, Mahbubul, та інші
Опубліковано: (2023)

Computational insights into molecular docking strategies for non-small cell lung cancer drug discovery
за авторством: Das, Reshita
Опубліковано: (2024)

A review on potential role of cannabinoids as therapeutic agents in different types of cancer
за авторством: Roy, Hredita
Опубліковано: (2018)

Tuberculosis associates with both airflow obstruction and low lung function: BOLD results
за авторством: F. S. Amaral, André, та інші
Опубліковано: (2017)

Clinical outcomes and safety comparison of gemcitabine plus cisplatin, capecitabine monotherapy, and gemcitabine plus oxaliplatin in the management of gallbladder carcinoma: a comprehensive meta-analysis
за авторством: Rahman, Sanjida
Опубліковано: (2024)

Prevalence and risk factors of chronic obstructive pulmonary disease in Bangladesh: A systematic review
за авторством: Sutradhar, Ipsita, та інші
Опубліковано: (2022)

Evaluation of genetics of cancer predisposition in patients and efficacy of various chemotherapeutic drugs in Bangladesh
за авторством: Hossain, Safa Binte
Опубліковано: (2019)

Statistics and informatics in molecular cancer research

Survey on patients undergoing treatments for cervical, endometrial and ovarian cancer
за авторством: Nawar, Anika
Опубліковано: (2019)

Cancer risk factors: a critical review
за авторством: Tabassum, Tahsina
Опубліковано: (2017)

Score based risk assessment of lung cancer and its evaluation for Bangladeshi people
за авторством: Mukti, Roushney Fatima, та інші
Опубліковано: (2016)

The current cancer situation in metropolitan Dhaka
за авторством: Morshid, Golam
Опубліковано: (2023)

Pulmonary patient compliance among different types of inhaler dosage forms in Mohakhali, Dhaka
за авторством: Rithin, Rafia Islam
Опубліковано: (2022)

A brief survey on the effect of smoke of different sources on COPD patients
за авторством: Nawal, Nusrat
Опубліковано: (2021)

Lung cancer immunosuppression and therapeutic targeting of myeloid- derived suppressor cells
за авторством: Nandy, Aditi
Опубліковано: (2022)

Comparing effectiveness and safety of combination therapy for esophageal and gastro esophageal junction cancer: a comprehensive meta-analysis
за авторством: Abir, Shifaty Nur
Опубліковано: (2024)

Targeting BRAFV600E in the treatment of CRC
за авторством: Roja, Mashwiyat Samrin
Опубліковано: (2024)

Application of NSAIDs in the treatment of pulmonary diseases- a comparative study of the therapeutic & the adverse impacts
за авторством: Rahman, Farhana
Опубліковано: (2021)

Role of statins as antagonists of SPARC in gastric cancer
за авторством: Shahmat, Rad
Опубліковано: (2019)

Pooled analysis of response rate and overall survival of Tyrosine Kinase inhibitor combinations in phase II clinical trials of non-small cell lung cancer
за авторством: Karim, Samia Binte
Опубліковано: (2024)

Epigenetic therapy in cancer
за авторством: Abid, Md. Shadman Ridwan
Опубліковано: (2021)

Current practice and approaches of immunotherapy in Cancer treatment
за авторством: Khondokar, Faiza
Опубліковано: (2022)

RIPK pathway, as a potential target, for cancer treatment - a review
за авторством: Jahan, Nusrat
Опубліковано: (2024)

A review of Breast Cancer risk factor assessment on women in developing countries, cancer drug resistance, and Breast Cancer treatment in Bangladesh
за авторством: Raihan, Dilraj
Опубліковано: (2024)

Biosimilar in lymphoma treatment
за авторством: Tanisha, Mehrin Haque
Опубліковано: (2021)